Baxter International Names John Rogers CFO as Leadership Reshuffle Continues
The medtech company has appointed a former Smith+Nephew and WPP finance chief to lead its turnaround efforts, with compensation package exceeding $7.7 million in year one.
New CFO to Lead Financial Turnaround
Baxter International Inc. announced the appointment of John Rogers as executive vice president and chief financial officer, effective October 1, 2026, as the $13 billion medtech company continues efforts to stabilize its business and strengthen its balance sheet (8-K filing, 2026-08-19).
Rogers, 58, joins from Smith+Nephew plc, where he has served as CFO since 2024. His appointment comes as part of a broader leadership transition, with interim CFO Anita Zielinski departing the company on September 15, 2026 (8-K filing, 2026-08-19).
"John is a proven global finance executive with extensive operational expertise and a successful track record leading complex transformation initiatives," said Andrew Hider, Baxter's president and CEO, in the company's press release (8-K filing, 2026-08-19).
Interim Arrangements During Transition
In an unusual move, Hider will serve as interim CFO during a two-week period from September 15 until Rogers' start date, while continuing in his role as CEO. Hider will receive no additional compensation for the dual responsibilities (8-K filing, 2026-08-19).
The company also appointed Bernie Heine, currently assistant controller, as interim chief accounting officer and controller effective September 15. Heine, 40, joined Baxter in 2023 after 15 years at PricewaterhouseCoopers, where he most recently served as an assurance director beginning in 2018 (8-K filing, 2026-08-19).
Compensation Package Details
Rogers' compensation package includes an annual base salary of $925,000 and a target annual bonus of 100% of base salary under the company's Management Incentive Compensation Program (8-K filing, 2026-08-19). He will participate in the annual equity program beginning with the 2027 grant, with a target annual equity value of $4 million (8-K filing, 2026-08-19).
The CFO will receive two off-cycle equity grants as compensation for unvested awards from his prior employer: one prorated grant for 2026 at the $4 million target value, and another valued at $3,861,494 (8-K filing, 2026-08-19). Both grants will consist of performance-based restricted stock units, restricted stock units, and stock options, with the performance period measured from January 1, 2026, through December 21, 2028 (8-K filing, 2026-08-19).
Rogers will also receive a sign-on bonus of $2,827,629 to replace incentive compensation from his prior employer. He must repay the full amount if his employment terminates within 12 months for most reasons, or 50% if termination occurs within 12 to 24 months (8-K filing, 2026-08-19).
Background and Outlook
Before joining Smith+Nephew, Rogers served as CFO of WPP plc from 2020 to 2023, where he led a global transformation program. He previously held senior roles at J Sainsbury plc, including CEO of Sainsbury's Argos from 2016 to 2019 and CFO of Sainsbury's from 2010 to 2016 (8-K filing, 2026-08-19).
Baxter reiterated its full-year 2026 financial outlook provided in its July 30, 2026, earnings announcement (8-K filing, 2026-08-19). According to MarginX data, the company is scheduled to present at the Wells Fargo 21st Annual Healthcare Conference on September 9, 2026.
This article was generated by MarginX from the 8-K filing on 2026-08-19. It is not investment advice.